Fingerprint
Dive into the research topics of 'Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy
Ferah Comert Onder, Pinar Siyah, Serdar Durdagi, Mehmet Ay, Bulent Ozpolat
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations